host
genet
determin
play
import
role
gener
regul
humor
cellular
immun
respons
vaccin
andor
infect
studi
measlesmumpsrubella
mmr
vaccin
immunogen
twin
previous
demonstr
high
level
herit
approxim
humor
immun
respons
varianc
follow
rubella
vaccin
multipl
host
gene
oper
gene
genenetwork
level
shape
regul
qualiti
durat
magnitud
rubella
vaccineinduc
humor
cellular
immun
respons
viral
attach
cell
entri
fusion
cell
membran
viral
genom
transloc
target
cell
essenti
earli
stage
initi
viral
infecti
cycl
key
step
viral
replic
dissemin
well
virushost
interact
involv
gener
mainten
immun
respons
recent
discoveri
point
role
newli
discov
cellular
receptor
attach
factor
sever
import
human
virus
includ
rubella
viru
myelin
oligodendrocyt
glycoprotein
mog
measl
viru
measl
viru
epitheli
cell
receptor
polioviru
receptorrel
gene
transmembran
ctype
lectin
rift
valley
fever
virusrvfv
polioviru
polioviru
receptor
herpesviru
polioviru
receptorrel
protein
infect
diseas
pathogenesi
immun
host
cell
surfac
receptor
attach
factor
plausibl
genet
regul
measl
vaccineinduc
immun
influenc
immun
rubella
vaccin
never
examin
current
candid
gene
associ
studi
follow
previous
found
genet
associ
also
make
use
recent
major
discoveri
virolog
field
explor
plausibl
role
select
cell
surfac
receptor
attach
factorrel
gene
mog
polioviru
receptorrel
gene
famili
member
genet
control
immun
respons
variat
live
rubella
vaccin
result
two
independ
studi
cohort
discoveri
replic
strongli
suggest
genet
variant
gene
play
role
modul
humor
immun
respons
follow
rubella
vaccin
studi
cohort
larg
populationbas
sampl
healthi
children
older
adolesc
healthi
adult
age
year
resid
rochest
mn
san
diego
ca
clinic
demograph
characterist
previous
report
rochest
cohort
compris
sampl
individu
three
independ
agestratifi
random
cohort
healthi
schoolchildren
young
adult
socioeconom
strata
olmst
counti
mn
enrol
publish
elsewher
eleven
hundr
one
parent
agre
let
children
join
current
rubella
vaccin
studi
juli
septemb
enrol
addit
healthi
older
adolesc
healthi
adult
age
year
san
diego
cohort
arm
forc
personnel
naval
health
research
center
nhrc
san
diego
ca
previous
describ
subject
includ
current
rubella
vaccin
studi
document
receipt
measlesmumpsrubella
mmr
vaccin
institut
review
board
mayo
clinic
nhrc
approv
studi
written
inform
consent
obtain
subject
parent
children
particip
studi
well
written
assent
ageappropri
particip
use
modifi
version
immunocolorimetricbas
neutral
method
describ
chen
et
al
optim
highthroughput
microformat
measur
rubella
virusspecif
neutral
antibodi
subject
sera
heatinactiv
hour
sera
serial
dilut
twofold
triplic
dilut
begin
yield
final
volum
per
dilut
use
phosphatebuff
salin
pb
ph
supplement
fetal
bovin
serum
fb
rubella
viru
stock
vaccin
viru
dilut
work
concentr
plaqueform
unit
pfu
ml
ad
equal
volum
dilut
serum
diluent
case
virusonli
control
yield
final
serum
dilut
seri
plate
incub
hour
fifti
microlit
mixtur
use
inocul
confluent
vero
cell
monolay
cultur
flatbottom
plate
cell
incub
hour
incub
period
dmem
supplement
fb
gentamicin
gibco
invitrogen
ca
usa
ad
well
plate
incub
hour
plate
develop
use
indirect
immunocolorimetr
method
rubella
monoclon
antibodi
center
diseas
control
preventioncdc
ga
usa
previous
describ
optic
densiti
od
valu
measur
use
measurementrefer
wavelength
pair
nm
neutral
titer
calcul
highest
dilut
input
viru
signal
reduc
least
within
dilut
seri
neutral
titer
loess
method
statist
interpol
use
estim
interpol
valu
observ
valu
intraclass
correl
coeffici
icc
base
logtransform
estim
sampl
repeat
measur
demonstr
high
degre
reproduc
assay
snp
select
genotyp
method
describ
herein
similar
ident
publish
previou
genet
associ
studi
genotyp
effort
includ
followup
previous
identifi
genet
associ
p
snp
immun
respons
gene
cytokin
cytokin
receptor
gene
tolllik
receptor
signal
gene
vitamin
vitamin
receptor
famili
gene
antivir
effector
innat
gene
immun
measur
rubella
vaccin
total
addit
snp
goldeng
panel
fill
candid
tagsnp
select
eight
newli
discov
viral
receptor
gene
mog
pvr
use
tagsnp
select
approach
base
linkag
disequilibrium
ld
previous
describ
snp
genotyp
use
custom
design
illumina
assay
illumina
inc
san
diego
ca
follow
manufactur
instruct
beadstudio
softwar
use
call
genotyp
genotyp
qualiti
high
mean
snp
call
rate
rochest
cohort
san
diego
cohort
respect
mean
subject
call
rate
estim
concord
duplic
rochest
cohort
remov
sampl
fail
genotyp
andor
qc
check
sampl
snp
avail
analysi
includ
sampl
snp
caucasianonli
analysi
san
diego
cohort
data
avail
analysi
subject
snp
includ
sampl
snp
caucasianonli
analysi
summari
subject
characterist
obtain
within
two
studi
cohort
count
percentag
categor
featur
median
interquartil
rang
percentil
continu
featur
princip
compon
analysi
larg
collect
independ
snp
appli
estim
defin
racial
group
previous
describ
rochest
cohort
predominantli
caucasian
data
cohort
subset
race
equilibrium
hwe
test
within
caucasian
subset
cohort
princip
compon
analysi
repeat
via
eigenstrat
collect
snp
except
low
linkag
disequilibrium
hwe
pvalu
nonautosom
snp
snp
minor
allel
frequenc
less
includ
popul
stratif
analys
produc
addit
race
cohortspecif
popul
stratif
eigenvector
linear
regress
model
model
quantit
neutral
antibodi
outcom
linear
combin
covari
snp
genotyp
variabl
use
assess
associ
neutral
antibodi
level
snp
genotyp
addit
genet
model
code
snp
genotyp
singl
variabl
reflect
number
minor
allel
carri
individu
use
primari
test
signific
sensit
analys
domin
recess
genet
effect
also
examin
associ
outcom
snp
altern
model
prove
superior
compar
addit
genet
model
use
primari
assess
signific
neutral
antibodi
level
analyz
phenotyp
interest
logarithm
transform
order
conform
linear
model
assumpt
snp
associ
assess
adjust
gender
assay
batch
effect
quartil
age
enrol
immun
age
time
sinc
last
immun
enrol
racespecif
popul
stratif
eigenvector
associ
test
independ
within
cohort
result
compar
two
cohort
order
determin
snp
potenti
associ
neutral
antibodi
titer
across
two
studi
cohort
fix
effect
metaanalysi
perform
snp
metaanalys
use
estim
effect
two
studi
cohort
combin
use
fix
effect
paradigm
obtain
pool
estim
effect
along
pool
standard
error
test
signific
addit
metaanalys
provid
test
heterogen
cohort
snp
display
signific
heterogen
two
cohort
p
metaanalysi
pvalu
less
consid
potenti
associ
neutral
antibodi
level
merit
followup
futur
studi
analys
carri
use
sa
softwar
system
sa
institut
inc
cari
nc
plink
whole
genom
data
analysi
softwar
packag
demograph
characterist
studi
cohort
report
previous
summar
tabl
briefli
rochest
discoveri
cohort
subject
met
inclus
exclus
qc
criteria
genotyp
rubella
neutral
antibodi
data
avail
studi
subject
caucasian
includ
final
analysi
san
diego
replic
cohort
subject
met
inclus
exclus
qc
criteria
genotyp
rubella
neutral
antibodi
data
avail
subject
caucasian
includ
final
analysi
median
age
enrol
year
iqr
rochest
cohort
year
iqr
san
diego
cohort
median
neutral
antibodi
level
rochest
cohort
san
diego
cohort
tabl
detail
character
immun
respons
variabl
studi
cohort
interrelationship
publish
previous
found
three
replic
genet
associ
snp
tag
polioviru
receptor
gene
pvr
nectinlik
protein
high
linkag
disequilibriumld
fig
rubellaspecif
neutral
antibodi
metaanalysi
pvalu
tabl
although
rel
rare
heterozyg
genotyp
pvr
snp
homozyg
minor
allel
genotyp
observ
consist
associ
signific
decreas
neutral
antibodi
titer
rubella
vaccin
cohort
similarli
heterozyg
genotyp
two
snp
ld
fig
gene
polioviru
receptorrel
herpesviru
entri
mediat
b
nectin
associ
signific
increas
rubellaspecif
neutral
antibodi
titer
metaanalysi
pvalu
respect
tabl
furthermor
five
addit
genet
variant
ld
fig
demonstr
evid
associ
rubellaspecif
titer
post
vaccin
metaanalysi
pvalu
tabl
although
find
associ
highlow
respons
consist
two
cohort
metaanalysi
also
reveal
potenti
associ
snp
promot
region
gene
rubellaspecif
neutral
antibodi
metaanalysi
pvalu
respect
tabl
found
replic
genet
associ
snp
intron
vitamin
receptor
gene
rarb
demonstr
signific
decreas
neutral
antibodi
titer
represent
minor
allel
metaanalysi
pvalu
tabl
homozyg
minor
allel
genotyp
snp
put
rubella
viru
receptor
gene
mog
myelin
oligodendrocyt
glycoprotein
associ
decreas
rubellaspecif
antibodi
metaanalysi
pvalu
tabl
addit
snp
snp
also
demonstr
evid
associ
rubellaspecif
titer
p
tabl
analysi
result
snp
assess
associ
neutral
antibodi
level
current
studi
present
tabl
much
knowledg
accumul
role
genet
factor
interindividu
immun
respons
variat
follow
immun
measlesmumpsrubella
mmr
vaccin
genomewid
transcript
studi
use
mrnaseq
high
low
antibodi
respond
rubella
vaccin
identifi
hla
gene
sever
innat
immun
inflammationrel
gene
mefv
mediterranean
fever
gene
egflik
modul
contain
mucinlik
hormon
receptorlik
gene
etc
discrimin
high
low
humor
immun
respons
follow
rubella
immun
other
highlight
import
hla
polymorph
snp
cytokin
cytokin
receptor
gene
antivir
gene
tolllik
receptor
pathway
signal
gene
vitamin
receptor
cellular
viral
receptor
gene
slam
measl
viru
import
innat
immun
gene
trim
gene
dcsign
etc
interindividu
immun
respons
variat
measl
rubella
vaccin
immun
respons
encompass
system
interrel
compon
biolog
process
like
multipl
genet
factor
gene
network
influenc
host
respons
vaccineinduc
immun
involv
antibodi
respons
includ
measl
rubella
vaccin
purpos
current
studi
refin
previou
find
replic
examin
two
independ
cohort
role
newli
discov
host
viral
receptor
attach
factor
immun
regul
adapt
immun
respons
induct
andor
mainten
follow
vaccin
live
rubella
vaccin
metaanalysi
result
provid
evid
involv
multipl
genet
variant
ld
within
gene
region
fig
chromosom
genet
control
neutral
antibodi
respons
rubella
vaccin
polioviru
receptor
pvr
polioviru
receptorrel
gene
encod
transmembran
glycoproteinsnectin
immunoglobulin
ig
superfamili
compon
adheren
junction
serv
cellular
entri
receptor
polioviru
pvr
pseudorabi
viru
certain
mutant
strain
herp
simplex
viru
virusspecif
cell
surfac
receptor
protein
import
function
downstream
effect
process
relat
viral
entri
viral
replic
celltocel
spread
viral
tropism
pathogenesi
antivir
immun
exampl
mutat
polioviru
receptor
gene
pvr
previous
associ
higher
risk
develop
vaccineinduc
wildtyp
virusinduc
poliomyel
furthermor
pvr
directli
involv
immun
regul
cell
ctl
natur
killernk
cell
activationcytotox
function
specif
ligand
immun
costimulatori
receptor
dnax
accessori
promot
product
importantli
may
play
role
differenti
humor
immun
polar
cell
phenotyp
particular
tlr
agonist
known
upregul
express
depend
trif
suppress
cell
differenti
modul
antigen
ova
specif
igg
titer
mous
model
consist
find
maier
et
al
demonstr
less
effici
humor
immun
respons
igg
iga
oral
administ
antigen
mice
defici
summari
base
literatur
find
specul
one
multipl
pvr
genet
variant
associ
variat
rubella
vaccinespecif
neutral
antibodi
level
tag
causal
snpsnp
region
influenc
gene
express
andor
protein
function
pvr
turn
may
downstream
effect
rubella
virusspecif
humor
immun
either
modul
unspecif
specif
viru
attachmententri
replic
immun
respons
prime
like
modul
cell
differenti
promot
less
effici
antibodi
respons
cellular
receptor
rubella
viru
identifi
date
myelin
oligodendrocyt
glycoprotein
mog
adhes
molecul
import
nerv
myelin
implic
target
antigen
pathogenesi
sever
autoimmun
demyelin
diseas
includ
multipl
scleros
central
nervou
system
cn
damag
congenit
rubella
syndrom
howev
rubella
viru
cell
tropism
infect
suggest
yet
undiscov
cellular
receptor
adhes
factor
capabl
mediat
infect
exist
pathogen
mog
express
predominantli
central
nervou
system
hardli
detect
immun
system
organstissu
cell
spleen
thymu
pbmc
analysi
identifi
two
intron
polymorph
p
p
tabl
mog
gene
highli
homolog
butyrophilin
gene
chromosom
associ
variat
rubellaspecif
neutral
antibodi
respons
host
genet
variat
tag
function
snp
may
potenti
impair
enhanc
viral
entri
suscept
cell
alter
viru
replicationpropag
antigen
abund
modul
subsequ
immun
respons
altern
gene
may
interfer
immun
regul
demonstr
butyrophilin
latter
costimulatori
molecul
implic
cell
inhibit
neg
regul
cell
prolifer
activ
cytokin
product
immun
signal
interact
dcsign
dendrit
cell
identifi
ligand
dcsign
genet
variat
gene
associ
inflammatori
diseas
note
result
also
demonstr
associ
promot
snp
dcsign
p
tabl
humor
immun
respons
variat
follow
rubella
vaccin
dcsign
cellspecif
intercellular
adhes
nonintegrin
ctype
lectin
mediat
dendrit
cell
function
activ
cell
bind
multipl
microorgan
includ
virus
recogn
mannos
type
glycoprotein
molecul
exploit
mani
virus
attach
andor
cellular
entri
measl
viru
mv
rift
valley
fever
viru
rvfv
influenza
virus
human
immunodefici
viru
hepat
c
viru
hcv
herp
simplex
viru
human
cytomegaloviru
hcmv
ebola
viru
sar
coronaviru
dengu
viru
polymorph
dcsign
particular
promot
snp
associ
clinic
cours
outcom
dengu
viru
infect
cytomegaloviru
infect
tickborn
enceph
viru
tbev
infect
pulmonari
aspergillosi
furthermor
promot
snp
function
demonstr
influenc
dcsign
gene
express
hcmc
infect
dendrit
cell
interestingli
found
dcsign
promot
snp
associ
variat
measl
vaccineinduc
secret
africanamerican
sever
dcsign
snp
associ
variat
measlesspecif
neutral
antibodi
level
caucasian
africanamerican
therefor
like
dcsign
pvr
attach
factor
andor
cellular
viral
receptor
pathwayrel
gene
involv
genet
control
rubella
vaccineinduc
immun
respons
heterogen
vaccin
anoth
import
find
observ
genet
associ
snp
intron
retino
acid
receptor
beta
rarb
gene
rubellaspecif
neutral
antibodi
respons
homozyg
minor
allel
heterozyg
genotyp
associ
lower
antibodi
titer
cohort
rarb
receptor
retino
acid
biolog
activ
metabolit
vitamin
involv
cell
growth
differenti
cell
signal
gene
regul
interestingli
vitamin
direct
effect
immun
system
regul
antigen
present
lymphocyt
home
prolifer
b
cell
thelper
differenti
cytokin
product
cell
activ
cytotox
well
enhanc
antibodi
respons
vaccin
includ
measl
vaccin
oral
polio
vaccin
tetanu
diphtheria
toxoid
furthermor
previou
studi
demonstr
associ
rarb
snp
p
two
rarb
snp
rubella
whole
virusspecif
igg
level
measur
chemiluminesc
immunoassay
childrenyoung
adult
follow
two
dose
mmr
vaccin
rarb
snpshaplotyp
variat
measlesspecif
neutral
antibodi
level
cellular
immun
outcom
mmr
vaccin
find
current
studi
previou
report
add
evid
import
vitamin
receptor
pathway
immun
respons
regul
immun
potenti
find
includ
snp
associ
polymorph
gene
promot
region
snp
gene
snp
gene
intron
snp
previous
found
associ
whole
rubella
virusspecif
igg
level
use
singlesnp
andor
multigen
assess
analysi
snp
associ
identifi
previou
studi
confirm
current
studi
possibl
due
differ
studi
design
sampl
size
cohort
characterist
analyt
approach
differ
immun
respons
measur
rubella
whole
virusspecif
igg
level
vs
rubella
virusspecif
neutral
antibodi
level
andor
falseposit
find
effort
identifi
collect
genet
variant
high
interest
potenti
play
role
variabl
neutral
antibodi
respons
rubella
vaccin
must
note
genet
associ
may
true
posit
limit
studi
reflect
fact
characterist
studi
particip
differ
two
studi
cohort
made
difficult
compar
andor
combin
result
two
cohort
use
method
would
typic
appli
control
falseposit
find
reason
appli
metaanalyt
approach
evalu
degre
evid
associ
present
evalu
combin
result
across
two
cohort
understand
falseposit
result
would
less
like
show
consist
associ
cohort
given
signal
observ
biolog
plausibl
like
least
sever
identifi
associationsgen
inde
play
role
influenc
neutral
antibodi
level
observ
vaccin
individu
addit
analysi
focus
addit
genet
effect
support
genet
model
addit
model
compellingli
strong
sensit
analys
possibl
genet
variant
altern
genet
model
may
prove
superior
limit
includ
influenc
unpredict
factor
confound
analysi
result
eg
potenti
wildtyp
rubella
viru
exposur
deploy
militari
personnel
san
diego
cohort
strength
studi
includ
use
clinic
relev
immun
outcom
assess
vaccin
respons
ie
rubellaspecif
functionalneutr
antibodi
level
measur
use
stateoftheart
standard
highthroughput
immun
assay
signific
strength
genet
associ
analysi
approach
adjust
known
confound
variabl
use
two
independ
cohort
subset
caucasian
subject
minim
falseposit
find
identifi
gene
genet
variant
fine
map
order
identifi
candid
function
variant
genom
region
tag
origin
snp
function
pvalu
magnitud
effect
obtain
finemap
analys
provid
import
insight
variant
like
caus
genet
associ
origin
observ
final
identif
like
causal
genet
variant
complement
function
studi
reveal
snp
immedi
function
effect
downstream
consequencesbiolog
mechan
humor
immun
respons
variat
summari
result
identifi
multipl
genet
variant
primarili
gene
relat
viral
attach
entri
andor
immun
regul
associ
interindividu
differ
rubellaspecif
neutral
antibodi
respons
vaccin
find
may
indic
evid
novel
receptor
use
rubella
viru
cell
entri
assist
develop
improv
vaccin
vaccin
formul
achiev
optim
immun
respons
vaccin
